Atgam

Atgam (Anti-T Lymphocyte Immunoglobulin) is a horse-derived medication used for immune system modulation. It is administered intravenously and is manufactured by Pfizer Europe MA EEIG.

Atgam is primarily used to suppress the immune system in certain medical conditions. It is often prescribed for organ transplant patients to prevent rejection or for autoimmune disorders where immune modulation is necessary. The medication works by targeting and reducing the number of T lymphocytes, which are a type of white blood cell involved in the immune response.

Common effects of Atgam may include fever, chills, and allergic reactions. Some patients might experience changes in blood pressure or heart rate. It is important to monitor for any signs of infusion-related reactions during administration.

Atgam should be administered under medical supervision due to the risk of severe allergic reactions. Patients with a history of allergies to horse proteins should exercise caution. Regular monitoring of blood counts and immune function is recommended during treatment.

Atgam may interact with other medications that affect the immune system. It is important to inform healthcare providers about all current medications, including over-the-counter drugs and supplements. Alcohol and certain foods may also influence the effectiveness or safety of Atgam.